Deal Watch: Roche Goes All-In On Real-World Data With Flatiron Acquisition
Executive Summary
Already a significant investor in the health care technology firm, buyout will give Roche access to substantial real-world cancer development data. Astellas acquires stem cell-focused Universal Cells.